TGIF2LY inhibitors are a class of chemical compounds specifically designed to target and inhibit the activity of the TGIF2LY protein, a member of the TGIF (thymine-rich, G-rich, and immunoglobulin-like factors) family involved in transcriptional regulation and developmental processes. TGIF2LY plays a crucial role in various cellular functions, including gene expression, cellular differentiation, and responses to signaling pathways. These inhibitors primarily function by binding to key regions of the TGIF2LY protein, such as its DNA-binding domain or other essential sites necessary for its interaction with transcriptional machinery. By occupying these critical binding sites, TGIF2LY inhibitors effectively disrupt the protein's ability to regulate target gene expression, leading to alterations in cellular activities and developmental processes. In some cases, these inhibitors may also act through allosteric mechanisms, where they bind to regions distinct from the active site, inducing conformational changes that impair the protein's functionality. The binding interactions between TGIF2LY inhibitors and the protein are typically stabilized by a variety of non-covalent forces, including hydrogen bonds, hydrophobic interactions, van der Waals forces, and ionic interactions, ensuring effective inhibition.
Structurally, TGIF2LY inhibitors exhibit significant diversity, which allows for specific interactions with different regions of the TGIF2LY protein. These inhibitors often incorporate functional groups such as hydroxyl, carboxyl, or amine groups, which facilitate strong interactions through hydrogen bonding and ionic interactions with critical amino acid residues in the protein's binding pockets. Many TGIF2LY inhibitors also feature aromatic rings or heterocyclic structures that enhance hydrophobic interactions with non-polar regions of the protein, contributing to the overall stability of the inhibitor-protein complex. The physicochemical properties of TGIF2LY inhibitors, including molecular weight, solubility, lipophilicity, and polarity, are meticulously optimized to ensure effective binding and stability in various biological environments. By achieving a balance between hydrophilic and hydrophobic regions, TGIF2LY inhibitors can selectively interact with both polar and non-polar areas of the protein, ensuring robust and efficient inhibition of TGIF2LY activity across diverse cellular contexts.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A inhibits histone deacetylases, leading to hyperacetylation of histones, which can suppress the transcription of certain genes, including TGIF2LY. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
This DNA methyltransferase inhibitor changes the methylation status of DNA, potentially downregulating genes like TGIF2LY. | ||||||
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | $131.00 $515.00 | 2 | |
RG108, also a DNA methyltransferase inhibitor, may lead to reduced expression of TGIF2LY through changes in DNA methylation. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Vorinostat, another histone deacetylase inhibitor, may alter chromatin structure and decrease TGIF2LY expression. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Sirolimus can inhibit mTOR signaling, which could decrease the transcription of certain genes, possibly including TGIF2LY. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
By inhibiting PI3K, LY294002 may affect transcriptional regulation pathways, potentially decreasing TGIF2LY expression. | ||||||
2-Deoxy-D-glucose | 154-17-6 | sc-202010 sc-202010A | 1 g 5 g | $70.00 $215.00 | 26 | |
This glycolysis inhibitor may create a cellular environment that indirectly leads to the downregulation of TGIF2LY expression. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $55.00 | 6 | |
It binds to GC-rich DNA sequences, potentially blocking the transcription factors binding and, consequently, the expression of TGIF2LY. | ||||||
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $90.00 $204.00 | 13 | |
Triptolide inhibits transcriptional activity in general, which could include repression of TGIF2LY expression. | ||||||
Flavopiridol Hydrochloride | 131740-09-5 | sc-207687 | 10 mg | $317.00 | ||
Flavopiridol inhibits cyclin-dependent kinases and may reduce transcription elongation, potentially affecting TGIF2LY expression. | ||||||